Immunogenicity and Safety Study of GSK Biologicals' Influenza Vaccine When Administered in Children
Clinical trial NCT01196988 · COMPLETED
Trial details
- NCT number
- NCT01196988
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-04
- Primary completion
- 2011-06-15
- Enrollment
- 3027
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.